These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 492214)

  • 1. Chloroquine-induced cytosomes with curvilinear profiles in muscle.
    Neville HE; Maunder-Sewry CA; McDougall J; Sewell JR; Dubowitz V
    Muscle Nerve; 1979; 2(5):376-81. PubMed ID: 492214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine-induced cardiomyopathy.
    McAllister HA; Ferrans VJ; Hall RJ; Strickman NE; Bossart MI
    Arch Pathol Lab Med; 1987 Oct; 111(10):953-6. PubMed ID: 2957973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural pathology of skeletal muscle in systemic lupus erythematosus.
    Finol HJ; Montagnani S; Márquez A; Montes de Oca I; Müller B
    J Rheumatol; 1990 Feb; 17(2):210-9. PubMed ID: 2319520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine-induced neuromyopathy. Report of a case.
    Parodi A; Regesta G; Rebora A
    Dermatologica; 1985; 171(3):203-5. PubMed ID: 4076494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine myopathy and myasthenia-like syndrome.
    Sghirlanzoni A; Mantegazza R; Mora M; Pareyson D; Cornelio F
    Muscle Nerve; 1988 Feb; 11(2):114-9. PubMed ID: 3343986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
    Bogaczewicz J; Sobów T; Bogaczewicz A; Robak E; Bienkowski P; Sysa-Jedrzejowska A; Wozniacka A
    Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropathy due to chloroquine in lupus erythematosus. 2 recent cases, emphasizing the necessity for ultrastructural study of the muscle biopsy].
    Godeau P; Herreman G; Himmich H; Godet-Guillain J; Chevallay M; Fardeau M
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):544-51. PubMed ID: 1008378
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
    Bezerra EL; Vilar MJ; da Trindade Neto PB; Sato EI
    Arthritis Rheum; 2005 Oct; 52(10):3073-8. PubMed ID: 16200586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. November 1998--70 year old woman with SLE, paraproteinemia and polyneuropathy.
    Bilbao JM
    Brain Pathol; 1999 Apr; 9(2):423-4. PubMed ID: 10219755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
    Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
    Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular changes and general condition in lupus erythematosus (SLE)--own observation].
    Brydak-Godowska J
    Klin Oczna; 2007; 109(1-3):11-4. PubMed ID: 17687904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].
    Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B
    Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
    Borba EF; Bonfá E
    J Rheumatol; 2001 Apr; 28(4):780-5. PubMed ID: 11327250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of systemic lupus erythematosus with various central and peripheral neurological disorders presenting with motor paralytic bladder as a major manifestation].
    Horiki T; Moriuchi J; Kouzuma R; Haida M; Watanabe S; Katsuoka Y; Ichikawa Y
    Ryumachi; 1995 Oct; 35(5):821-6. PubMed ID: 8594661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells.
    Grisar J; Steiner CW; Bonelli M; Karonitsch T; Schwarzinger I; Weigel G; Steiner G; Smolen JS
    Rheumatology (Oxford); 2008 Oct; 47(10):1476-83. PubMed ID: 18660509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.